Deals this week: Shockwave Medical, Theraclion, Pacific Edge

13 October 2017 (Last Updated October 16th, 2017 10:30)

Shockwave Medical Inc has secured an additional $35m in a series C venture financing round led by Fidelity Management and Research Company.

Shockwave Medical Inc has secured an additional $35m in a series C venture financing round led by Fidelity Management and Research Company.

The US-based company had previously secured $45m last November, while the latest round has increased the total funding to $80m.

The company plans to use the funds to develop its Peripheral and Coronary Lithoplasty Systems in the US and Europe.

Theraclion SA has signed an agreement with EDAP TMS SA to distribute its Echopulse system in France.

Both companies involved in the transaction are based in France.

“The US-based ophthalmic company plans to use the funds towards establishing a marketing team and to launch new products.”

New Zealand-based cancer diagnostics company Pacific Edge Ltd has announced a rights offering of 66 million shares priced at $0.32 a share to raise $21.3m.

Avita Medical Ltd has announced the rights offering of 276.5 million shares priced at A$0.05 ($0.3) each to raise A$12.44m ($9.65m). The company previously announced the private placement of 101 million shares priced at A$0.05 ($0.3) a share to raise A$4.5m ($3.49m).

The US-based medical device company plans to use the funds towards working capital purposes.

Sight Sciences Inc has secured $10m in a series C financing round led by Allegro Investment Fund.

The US-based ophthalmic company plans to use the funds towards establishing a marketing team and to launch new products.